HomeEducationNeuro-Urology News CONTROVERSY IN NEURO-UROLOGY: Is there any...

CONTROVERSY IN NEURO-UROLOGY: Is there any relationship between Covid-19 and Lower Urinary Tract Symptoms (LUTS)?

Covid-19 and LUTS

Have you experience with patients that started with LUTS with or after Covid-19 positive results? Please be so kind to fill in this short survey. Many thanks in advance!

Dear colleagues,

The new severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) causing coronavirus disease 2019 (COVID-19) has led to an international health crisis. Nearly 5% of patients require intensive care unit (ICU) management, and the clinical presentation is dominated by acute respiratory distress syndrome (ARDS). In addition to life-threatening respiratory distress, other potentially fatal complications have been described:  Acute Respiratory Failure Pneumonia, Acute Liver Injury, Acute Cardiac Injury, Secondary Infection, Septic Shock, Disseminated Intravascular Coagulation, Blood Clots, Multisystem Inflammatory Syndrome in Children, Rhabdomyolysis and Acute Kidney Injury.

However, there is no evidence of impact on the lower urinary tract. A patient with this association triggered the question: Is there any relationship between Covid-19 and LUTS? Could this new disease cause NLUTS? This updated and highly interesting topic motivated us to prepare a Survey. We would really appreciate if any of you had any experience to share with us and take your time to answer the few questions , depending on your experience this will take you just a few minutes or up to 15 minutes.  Click here to access the survey.

Of course we would also be happy if you left your valuable comment below to discuss your experience also with other INUS members or send an e-mail with your comments to the INUS Office.

We would also appreciate if you could share the survey link (https://www.neuro-uro.org/page.cfm?vpath=research/covid-19) with interested colleagues to further enhance the reach of it.

Back

LogIn

Please enter your email and password to login.